NCT01182415 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Autologous stem cell transplant: Autologous stem cell transplant following high-dose chemotherapy High-dose chemotherapy: High-dose chemotherapy with rituximab, thiotepa, busulfan, and cyclosphosphamide
- id
- FG000
- title
- High-dose Chemotherapy With Autologous Stem Cell Transplant
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Lost to Follow-up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 30
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 29
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 1
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Autologous stem cell transplant: Autologous stem cell transplant following high-dose chemotherapy High-dose chemotherapy: High-dose chemotherapy with rituximab, thiotepa, busulfan, and cyclosphosphamide
- id
- FG000
- title
- High-dose Chemotherapy With Autologous Stem Cell Transplant
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Lost to Follow-up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 30
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 29
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 1
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle